Allworth Financial LP Spring Works Therapeutics, Inc. Transaction History
Allworth Financial LP
- $17.4 Billion
- Q1 2025
A detailed history of Allworth Financial LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 11 shares of SWTX stock, worth $508. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11Holding current value
$508% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding SWTX
# of Institutions
258Shares Held
67.1MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.08MShares$327 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$260 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$160 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$151 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$139 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.88B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...